Neurological Genetic Disorders tests in Dubai & UAE

Compare available Neurological Genetic Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetic Disorders test prices

Showing 16–21 of 21 matching tests.

Neurological Genetic Disorders diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3722 RNASEH2B Gene Aicardi-Goutières Syndrome Type 2 Genetic Test This test evaluates the RNASEH2B gene for pathogenic variants associated with Aicardi-Goutières Syndrome Type 2 (AGS2). It uses Next-Generation Sequencing (NGS) to detect mutations...	Blood (Whole Blood, Serum, or Plasma)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RNASEH2B gene sequence", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Suspected Aicardi-Goutières Syndrome Type 2", "Familial screening for AGS2", "Genetic counselling for families with AGS2"] Measurement technique Confirm with laboratory Codes LOINC: 83267-5 ICD-10: G31.81 Clinical summary This test evaluates the RNASEH2B gene for pathogenic variants associated with Aicardi-Goutières Syndrome Type 2 (AGS2). It uses Next-Generation Sequencing (NGS) to detect mutations, insertions, deletions, and copy number changes.
TEST-3807 SEPT9 Gene Hereditary Neuralgic Amyotrophy (HNA) Genetic Test This genetic test analyzes the SEPT9 gene for mutations associated with Hereditary Neuralgic Amyotrophy (HNA).	Peripheral whole blood collected in EDTA tube	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SEPT9 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Complete a pre-genetic counselling session", "Provide a three-generation family pedigree"] Indications ["Suspected Hereditary Neuralgic Amyotrophy (HNA)", "Family history of HNA", "Recurrent brachial plexus neuropathy"] Measurement technique Confirm with laboratory Codes LOINC: 77418-8 ICD-10: G54.9 Clinical summary This genetic test analyzes the SEPT9 gene for mutations associated with Hereditary Neuralgic Amyotrophy (HNA).
TEST-4253 SLC13A5 Gene Early Infantile Epileptic Encephalopathy Type 25 (EIEE25) Genetic Test This genetic test identifies pathogenic variants in the SLC13A5 gene associated with early infantile epileptic encephalopathy type 25 (EIEE25).	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC13A5 gene", "Single nucleotide changes", "Indels", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting or special preparation is necessary"] Indications ["Neonates and children with drug-resistant epilepsy", "Profound developmental delay", "Dystonic movements", "Abnormal EEG and MRI findings"] Measurement technique Confirm with laboratory Codes LOINC: 87153-8 ICD-10: G40.4 Clinical summary This genetic test identifies pathogenic variants in the SLC13A5 gene associated with early infantile epileptic encephalopathy type 25 (EIEE25).
TEST-3736 SLC16A2 Gene Allan-Herndon-Dudley Syndrome Genetic Test This genetic test evaluates the SLC16A2 gene for mutations associated with Allan-Herndon-Dudley syndrome.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC16A2 gene sequence", "Point mutations", "Insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Genetic counselling session required before sample collection", "Completed three-generation pedigree chart required"] Indications ["Suspected Allan-Herndon-Dudley syndrome based on clinical presentation", "Family history of Allan-Herndon-Dudley syndrome", "Carrier screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 29564-7 ICD-10: Q87.8 Clinical summary This genetic test evaluates the SLC16A2 gene for mutations associated with Allan-Herndon-Dudley syndrome.
TEST-4239 TOR1A Gene (DYT1) Next‑Generation Sequencing (Genetic Test This genetic test identifies mutations in the TOR1A gene, specifically the GAG deletion, associated with early-onset primary torsion dystonia (DYT1).	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	21–28 Calendar Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TOR1A gene sequence", "GAG deletion (c.907_909delGAG)"] Parameters [] Preparation ["No special preparation required"] Indications ["Suspected early-onset primary torsion dystonia", "Family history of DYT1", "Genetic counselling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 94760-6 ICD-10: G24.1 Clinical summary This genetic test identifies mutations in the TOR1A gene, specifically the GAG deletion, associated with early-onset primary torsion dystonia (DYT1).
TEST-5479 TWNK Gene Perrault Syndrome Type 5 Next-Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants in the TWNK gene, confirming a diagnosis of Perrault syndrome type 5.	Whole Blood (3–5 mL), Buccal Swab, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TWNK gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Pre-test genetic counseling is mandatory"] Indications ["Individuals with clinical features suggestive of Perrault syndrome", "Family history of Perrault syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the TWNK gene, confirming a diagnosis of Perrault syndrome type 5.

Category overview

Neurological Genetic Disorders: overview

Understanding the broader hereditary factors affecting your central and peripheral nervous systems empowers you to manage chronic, overlapping symptoms and make highly informed health decisions. Representing an expansive offering within our advanced Genetics services, testing for Neurological Genetic Disorders utilizes comprehensive multi-gene panels to evaluate the complex pathways linked to hereditary spastic paraplegias, leukodystrophies, and familial seizure disorders. Utilizing cutting-edge genomic technology, this robust screening delivers the definitive clarity needed to diagnose complex neurological cases, safely guiding highly customized neurology oversight, proactive physical rehabilitation, and specialized genetic counseling. Consistently ranked among the top diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic precision, and prompt, reliable reporting. Prioritize your lifelong neurological wellness—book your neurological genetic disorders testing in UAE, arrange a secure clinical sample transfer, or reach out to our dedicated medical genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.